QuickCool AB (publ) signs distribution agreements for Portugal
QuickCool AB (publ) (”QuickCool”) has signed distribution agreement for Portugal with ATN Medical Lda.
ATN Medical has a well-established network of KOLs and customers in Portugal. This is QuickCool’s second distribution agreement. Preparatory sales activities start immediately, but no sales will occur until after the QuickCool® SYSTEM has acquired the CE-mark.
QuickCool, that develops a patented intranasal cooling solution for patients who have suffered from sudden cardiac arrest, has signed its second distribution agreement for Portugal, with ATN Medical Lda.
”We had the luxury of choosing our long-term partner in Portugal. We decided to continue our strategy of choosing a smaller company that has the same passion and ambition as we. Eventually, it was an easy decision to take, after having met with the management team of ATN Medical Lda, in Porto. They are committed and engaged, and have an already well-established network of Key Opinion Leaders (KOLs) and customers throughout Portugal, from which we will benefit from the first day”, says Fredrik Radencrantz, CEO at QuickCool.
ATN Medical Lda was founded three years ago and distributes medical devices in the areas of Neurosurgery, Spine surgery, Intensive Care and respiratory (medication Delivery), with the representation of other international brands. ATN Medical Lda has complementary products and is a company that is well-known for “its focus on continuous and specialized training to realize the full potential of the products we sell”, says Nuno Carvalho, General Manager at ATN Medical Lda.
“We are a dynamic and innovative company that offers customized solutions that optimize the effectiveness of the healthcare professionals and improve the clinical outcome for patients. QuickCool’s solution fits perfectly into our strategy of expanding our market share within the area of ICUs. The ease-of-use is in line with our philosophy. We are looking forward to a successful partnership”, Nuno Carvalho, General Manager at ATN Medical Lda., says.
ATN Medical Lda.
ATN Medical Lda., has the distribution rights to other MedTech products such as probes for measure intracranial pressure (ICP), real-time measurements of tissue perfusion (CBF), VP programmable Shunts, EVD (external ventricular drainage), custom made cranial implants that are products used during neurosurgery and more, that target many needs within neurosurgery, Spine surgery and intensive care units. Regional sales representatives cover the whole Portuguese market. Dedicated service and training professionals ensure both clinical and product training and after-sales support.
For more information, please contact:
Fredrik Radencrantz, VD
Telefon: 046-286 38 40
E-post: fredrik.radencrantz@quickcool.se
This information is such that QuickCool AB is required to make public in accordance with the EU’s market abuse regulation (MAR) and the Swedish Securities Market Act. The information was made publicly available by the Company’s contact person on 25 October, 2018.
QuickCool is a Swedish medical technology company, whose business concept is to save lives and prevent brain damage in acute ischemia (Inadequate blood supply to the brain) by developing and providing a unique and globally patented cooling system, the QuickCool® SYSTEM. QuickCool is active in the fast-growing market, Targeted Temperature Management (TTM), for brain-protective cooling treatment of patients with e.g. acute cardiac arrest and stroke. QuickCool’s solution protects the brain by cooling in the nasal cavity and thus takes advantage of the innate heat exchanger in the nose. QuickCool’s Intranasal method offers gentle and uninterrupted cooling treatment for sedated patients. Quickcool is listed on Spotlight Stock Market and conducts its business at Ideon Science Park in Lund. For more Information, please refer to www.quickcool.se
Tags: